Update in antifungal therapy of dermatophytosis

Mycopathologia

Volumn 166, Issue 5-6, 2008, Pages 353-367

  Gupta, Aditya K ^a,b,c   Cooper, Elizabeth A ^c  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MEDIPROBE RESEARCH INC   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

ADULT; CHILD; DERMATOMYCOSIS; HAND DISEASE; HUMAN; MICROBIOLOGY; ONYCHOMYCOSIS; REVIEW; SKIN DISEASE; TINEA CAPITIS; TINEA PEDIS;

ADULT; ANTIFUNGAL AGENTS; CHILD; DERMATOMYCOSES; FOOT DERMATOSES; HAND DERMATOSES; HUMANS; ONYCHOMYCOSIS; TINEA CAPITIS; TINEA PEDIS;

EID: 55149116297     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-008-9109-0     Document Type: Review

References (82)

1. DS Loo 2006 Systemic antifungal agents: an update of established and new therapies Adv Dermatol 22 101 24
2. M Lecha I Effendy M Feuilhade de Chauvin N Di Chiacchio R Baran 2005 Treatment options-development of consensus guidelines J Eur Acad Dermatol Venereol 19 Suppl 1 25 33
3. TARO Pharmaceuticals Inc. Clotrimazole cream USP, 1%. Prescribing information. Bramalea, Ontario, Canada, June 1996.
4. TARO Pharmaceuticals Inc. Econazole nitrate cream 1%. Prescribing information. Brampton, Ontario, Canada, September 2001.
5. Merz Pharmaceuticals. Naftin® Naftifine HCl 1% gel/cream. Prescribing information. Greensboro, NC, USA, May 2007.
6. McNeil Consumer & Specialty Pharmaceuticals. Nizoral® (ketoconazole) 2% shampoo. Prescribing information. Fort Washington, PA, USA, October 2003.
7. TARO Pharmaceuticals Inc. Ciclopirox olamine cream USP, 0.77%. Prescribing information. Brampton, Ontario, Canada, March 2005.
8. MEDICIS, The Dermatology Company. Loprox® Gel (ciclopirox) 0.77%. Prescribing information. Scottsdale, AZ, USA, July 2005.
9. BERTEK Pharmaceuticals Inc. Mentax®-TC (butenafine HCl) cream, 1%. Prescribing information. Research Triangle Park, NC, USA, October 2002.
10. GlaxoSmithKline Consumer Healthcare LP. Oxistat® (oxiconazole nitrate cream) cream 1%; Oxistat® (oxiconazole nitrate lotion) lotion 1%. Prescribing information. Pittsburgh, PA, USA, January 2004.
11. AK Gupta M Chow CR Daniel R Aly 2003 Treatments of tinea pedis Dermatol Clin 21 431 62
12. Lamisil® (terbinafine hydrochloride tablets) Prescribing information. Novartis Pharmaceuticals Corporation. East Hanover, NJ, November 2005.
13. Sporanox® (itraconazole) Capsules prescribing information (Ortho-McNeil Inc). Janssen Pharmaceutica Products, L.P. Titusville, NJ, June 2006.
14. Diflucan® (fluconazole tablets) (fluconazole injection-for intravenous infusion only) (fluconazole for oral suspension) Prescribing information. Pfizer Inc, August 2004.
15. Griseofulvin (Systemic). In: Drug information for the health care professional, USP DI, The United States Pharmacopeial Convention, Inc., ed 24, Taunton MA, 2004, Micromedex, p. 1493-6.
16. Miscellaneous Antifungals-Griseofulvin. In: AHFS Drug Information® 2005. Bethesda, MD, 2005, American Society of Health-System Pharmacists, Inc., p. 535-7.
17. Azoles-Ketoconazole. In: AHFS Drug Information® 2005. Bethesda, MD, 2005, American Society of Health-System Pharmacists, Inc., p. 510-6.
18. AK Gupta EA Cooper F Montero-Gei 2003 The use of fluconazole to treat superficial fungal infections in children Dermatol Clin 21 537 42
19. AK Gupta EA Cooper G Ginter 2003 Efficacy and safety of itraconazole use in children Dermatol Clin 21 521 35
20. AK Gupta EA Cooper CW Lynde 2003 The efficacy and safety of terbinafine in children Dermatol Clin 21 511 20
21. AK Gupta JE Ryder 2003 The use of oral antifungal agents to treat onychomycosis Dermatol Clin 21 469 79
22. Antifungals, Azole (Systemic). In: Drug information for the health care professional, USP DI, The United States Pharmacopeial Convention, Inc., ed 24, Taunton MA, 2004, Micromedex. p. 315-23.
23. Padhye AA, Weitzman I. The dermatophytes. In: Collier L, Balows A, Sussman M, Ajello L, Hay RJ, editors. Topley and Wilson's medical mycology. New York: Oxford University Press; 1998. p. 215-36.
24. SL Noble RC Forbes PL Stamm 1998 Diagnosis and management of common tinea infections Am Fam Physician 58 163 8
25. Crawford F, Hollis S. Topical treatments for fungal infections of the skin and nails of the foot. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD001434.
26. AK Gupta EA Cooper JE Ryder 2004 Optimal management of fungal infections of the skin, hair, and nails Am J Clin Dermatol 5 225 37
27. Crawford F. Athlete's foot. In: Williams H, Bigby M, Diepgen T, Herxheimer A, Naldi L, Rzany B, editors. Evidence based dermatology. London: BMJ Books; 2003. p. 436-40.
28. AK Gupta M Chaudhry B Elewski 2003 Tinea corporis, tinea cruris, tinea nigra, and piedra Dermatol Clin 21 395 400
29. AK Gupta P De Doncker A Heremans 1997 Itraconazole for the treatment of tinea pedis: a dose of 400 mg/day given for 1 week is similar in efficacy to 100 or 200 mg/day given for 2 to 4 weeks J Am Acad Dermatol 36 789 92
30. J Faergemann NJ Mork A Haglund 1997 A multicentre (double-blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris Br J Dermatol 136 575 7
31. A Stary E Sarnow 1998 Fluconazole in the treatment of tinea corporis and tinea cruris Dermatology 196 237 41
32. P Suchil F Montero Gei M Robles 1992 Once-weekly oral doses of fluconazole 150 mg in the treatment of tinea corporis/cruris and cutaneous candidiasis Clin Exp Dermatol 17 397 401
33. TS Haroon HA Asghar S Aman 1997 An open, non-comparative study for the evaluation of oral fluconazole in the treatment of tinea corporis Specialist 13 417 23
34. M Papini EM Difonzo P Cilli 1997 Itraconazole versus fluconazole, a double-blind comparison in tinea corporis J Mycol Méd 7 77 80
35. A Kotogyan Y Harmanyeri A Tahsin Gunes 1996 Efficacy and safety of oral fluconazole in the treatment of patients with tinea corporis, cruris or pedis or cutaneous candidiasis. A multicentre, open, non-comparative study Clin Drug Investig 12 59 66
36. M Gomez R Arenas JJ Salazar 1996 Tinea pedis. A multicentre trial to evaluate the efficacy and tolerance of a weekly dose of fluconazole Dermatol Rev Mex 40 251 5 Spanish
37. R Del Aguila F Montero Gei M Robles 1992 Once-weekly oral doses of fluconazole 150 mg in the treatment of tinea pedis Clin Exp Dermatol 17 402 6
38. AK Gupta JE Ryder M Chow EA Cooper 2005 Dermatophytosis: the management of fungal infections Skinmed 4 305 10
39. JT Trent D Federman RS Kirsner 2001 Common viral and fungal skin infections Ostomy Wound Manage 47 28 34
40. P De Doncker AK Gupta G Marynissen 1997 Itraconazole pulse therapy for onychomycosis and dermatomycoses: an overview J Am Acad Dermatol 37 969 74
41. D Parent J Decroix M Heenen 1994 Clinical experience with short schedules of itraconazole in the treatment of tinea corporis and/or tinea cruris Dermatology 189 378 81
42. AK Gupta RC Summerbell 2000 Tinea capitis Med Mycol 38 255 87
43. BJ Roberts SF Friedlander 2005 Tinea capitis: a treatment update Pediatr Ann 34 191 200
44. J Lipozencic M Skerlev R Orofino-Costa 2002 A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species Br J Dermatol 146 816 23
45. AK Gupta AR Skinner 2004 Onychomycosis in children: a brief overview with treatment strategies Pediatr Dermatol 21 74 9
46. A Tosti BM Piraccini M Iorizzo 2003 Management of onychomycosis in children Dermatol Clin 21 507 9
47. Y Chan SF Friedlander 2004 New treatments for tinea capitis Curr Opin Infect Dis 17 97 103
48. TS Haroon I Hussain S Aman 1996 A randomized double-blind comparative study of terbinafine for 1, 2 and 4 weeks in tinea capitis Br J Dermatol 135 86 8
49. SF Friedlander R Aly B Krafchik 2002 Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration-finding study Pediatrics 109 602 7
50. J Lipozencic M Skerlev R Orofino-Costa 2002 A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species Br J Dermatol 146 816 23
51. AK Gupta RS Solomon P Adam 1998 Itraconazole oral solution for the treatment of tinea capitis Br J Dermatol 139 104 6
52. L Dastghaib M Azizzadeh P Jafari 2005 Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole J Dermatolog Treat 16 43 6
53. F Montero Gei 1998 Fluconazole in the treatment of tinea capitis Int J Dermatol 37 870 1
54. AK Gupta N Dlova P Taborda 2000 Once weekly fluconazole is effective in the treatment of tinea capitis: a prospective, multicentre study Br J Dermatol 142 965 8
55. AK Gupta RK Scher 1997 Management of onychomycosis: a North American perspective Dermatol Ther 3 58 65
56. Gupta AK, Ryder J, Bluhm R. Onychomycosis. In: Williams H, Bigby M, Diepgen T, Herxheimer A, Naldi L, Rzany B, editors. Evidence based dermatology. London: BMJ Books; 2003. p. 441-68.
57. A Tavakkol S Fellman F Kianifard 2006 Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in Onychomycosis-Concomitant Lamisil® and Debridement (IRONCLAD®), an open-label, randomized trial Am J Geriatr Pharmacother 4 1 13
58. LP Potter SD Mathias M Raut 2007 The impact of aggressive debridement used as an adjunct therapy with terbinafine on perceptions of patients undergoing treatment for toenail onychomycosis J Dermatolog Treat 18 46 52
59. CR Daniel III 1996 Traditional management of onychomycosis J Am Acad Dermatol 35 S21 5
60. B King 2003 Pain at first dressing change after toenail avulsion: the experience of nurses, patients and an observer: 1 J Wound Care 12 5 10
61. C Seebacher D Brasch O Abeck 2007 Onychomycosis Mycoses 50 321 7
62. Baran R, Hay RJ, Haneke E, Tosti A. Review of current antifungal treatment. Onychomycosis: the current approach to diagnosis and therapy. London: Martin Dunitz Ltd.; 1999. p. 44-69.
63. Hay RJ, Baran R, Haneke E. Fungal (onychomycosis) and other infections involving the nail apparatus. In: Baran R, Dawber RPR, de Berker DAR, Haneke E, Tosti A, editors. Baran and Dawber's diseases of the nails and their management. Osney Mead, Oxford: Blackwell Science Ltd.; 2001. p. 129-71.
64. C Grover S Bansal S Nanda 2007 Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial Br J Dermatol 157 364 8
65. R Baran A Kaoukhov 2005 Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy J Eur Acad Dermatol Venereol 19 21 9
66. Penlac® Nail Lacquer (ciclopirox) Topical Solution, 8% Prescribing information. Dermik Laboratories (a division of Sanofi-Aventis). Bridgewater, NJ, July 2006.
67. AK Gupta JE Ryder AR Skinner 2004 Treatment of onychomycosis: pros and cons of antifungal agents J Cutan Med Surg 8 25 30
68. EM Warshaw KR Clair 2005 Prevention of onychomycosis reinfection for patients with complete cure of all 10 toenails: results of a double-blind, placebo-controlled, pilot study of prophylactic miconazole powder 2% J Am Acad Dermatol 53 717 20
69. CR Daniel AK Gupta MP Daniel CM Daniel 1997 Two feet-one hand syndrome: a retrospective multicenter survey Int J Dermatol 36 658 60
70. B Sigurgeirsson BE Elewski PA Rich 2006 Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: a randomized, double-blind comparison J Dermatolog Treat 17 38 44
71. JJ Finch EM Warshaw 2007 Toenail onychomycosis: current and future treatment options Dermatol Ther 20 31 46
72. JH Olafsson B Sigurgeirsson R Baran 2003 Combination therapy for onychomycosis Br J Dermatol 149 Suppl 65 15 8
73. EGV Evans 2003 Drug synergies and the potential for combination therapy in onychomycosis Br J Dermatol 149 Suppl 65 11 3
74. MA Nandedkar-Thomas RK Scher 2005 An update on disorders of the nails J Am Acad Dermatol 52 877 87
75. AK Gupta Onychomycosis Combination Therapy Study Group 2005 Ciclopirox topical solution, 8% combined with oral terbinafine to treat onychomycosis: a randomized, evaluator-blinded study J Drugs Dermatol 4 481 5
76. R Baran 2001 Topical amorolfine for 15 months combined with 12 weeks of oral terbinafine, a cost-effective treatment for onychomycosis Br J Dermatol 145 Suppl 60 15 9
77. M Lecha 2001 Amorolfine and itraconazole combination for severe toenail onychomycosis: results of an open randomized trial in Spain Br J Dermatol 145 Suppl 60 21 6
78. JM Binstock 2007 Molecular biology techniques for identifying dermatophytes and their possible use in diagnosing onychomycosis in human toenails J Am Podiatr Med Assoc 97 134 44
79. D de Assis Santos RA de Carvalho Araujo LM Kohler 2007 Molecular typing and antifungal susceptibility of Trichophyton rubrum isolates from patients with onychomycosis pre- and post-treatment Int J Antimicrob Agents 29 563 9
80. A Brillowska-Dabrowska DM Saunte MC Arendrup 2007 Five-hour diagnosis of dermatophyte nail infections with specific detection of Trichophyton rubrum J Clin Microbiol 45 1200 4
81. C Savin S Huck C Rolland 2007 Multicenter evaluation of a commercial PCR-enzyme-linked immunosorbent assay diagnostic kit (Onychodiag) for diagnosis of dermatophytic onychomycosis J Clin Microbiol 45 1205 10
82. AK Gupta M Zaman J Singh 2007 Fast and sensitive detection of Trichophyton rubrum DNA from the nail samples of patients with onychomycosis by a double-round polymerase chain reaction-based assay Br J Dermatol 157 698 703